chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site pain, Vaccination site swelling
Clinical narrative: swelling and pain at injection site; swelling and pain at injection site; This is a spontaneous report from a contactable consumer (patient himself). A 80-years-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number was not reported), via an unspecified route of administration on 15Feb2021 (yesterday) as DOSE 1, SINGLE for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. On an unknown date in February2021, the patient experienced swelling and pain at injection site. The nurse gave him the injection, he didn't even feel it. The patient wanted to know how long it may last and if there is any treatment for it. The outcome of the events was unknown. There was no product quality complaint (PQC) present.   Follow-up attempts are completed. No further information is expected.
Age: 80.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Pain in extremity
Clinical narrative: sore arm, & tiredness; sore arm, & tiredness; This is a spontaneous report from a contactable consumer or other non hcp.     An 80-years-old male patient received bnt162b2 (BNT162B2 PFIZER-BIONTECH COVID-19 MRNA VACCINE; Solution for injection (Batch/Lot number was not reported), dose 1 via an unspecified route of administration on 13Feb2021 as dose 1, single for covid-19 immunisation.The patient medical history and concomitant was not reported. It was Reported that, the patient experienced sore arm, & tiredness on an unspecified date with outcome of unknown.    Information about lot/batch number has been requested.  Follow-up attempts are completed. No further information is expected.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Dizziness, Headache, Nausea, Pain in extremity
Clinical narrative: chills; nausea; headache; dizziness; sore arm; This is a spontaneous report from a contactable consumer (patient). A 67-years-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection, Batch/Lot Number: EL9267, Expiry Date: 31May2021), via an unspecified route of administration, administrated in right arm on 13Feb2021 16:40 (age at the time of vaccination 67-years-old), as a single dose for COVID-19 immunization. The patient's medical history included Asthma, and some allergies to medications. The patient's concomitant medications were not reported. On 14Feb2021, the patient experienced sore arm; on 15Feb2021 nausea, headache, dizziness, and 16Feb2021 chills. Caller would like to know how long she should expect these symptoms to continue. No further information provided. The outcome for all the events was not recovered; and dizziness was recovering.  Follow-up (17Jun2021): Follow-up attempts completed. No further information expected.
Sex: F
Vaccine: COVID19
Symptoms: Musculoskeletal stiffness
Clinical narrative: stiff neck; This is a spontaneous report from a contactable consumer or other non hcp. An elderly female (age: 73; unit: unknown) patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection), dose 1 via an unspecified route of administration on 10Feb2021 (Batch/Lot number was not reported) as dose 1, single for covid-19 immunisation. Medical history included arthritis from an unknown date and unknown if ongoing (has a history of arthritis and has had to have steroid shots in the back). The patient experienced stiff neck on an unspecified date. She states that she's has developed a stiff neck, and has a history of arthritis and has had to have steroid shots in the back. She went to the ER and her doctor suggested getting cortisone shots in her neck. She wants to know if it will affect the efficacy of the vaccine. The outcome for event was unknown.   Follow-up attempts are completed. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Lymphadenopathy, Musculoskeletal discomfort, Myalgia, Neck pain, Neuralgia
Clinical narrative: achy and sored; she felt "nerve pain and muscle pain in [her] neck; hot in the back of [her] neck; nerve pain and muscle pain in [her] neck; swollen lymph node in the at the back of [her] head and under [her] arm; she felt "nerve pain and muscle pain in [her] neck; This is a spontaneous report from a contactable consumer or other non hcp (Patient).  A 37-years-old female patient received second dose of bnt162b2 (BNT162B2, PFIZER-BIOTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number was not reported), via an unspecified route of administration on 08Feb2021 as single dose for covid-19 immunization. No medical history and no concomitant medications were not reported. Historical vaccine included first dose of BNT162B2 for Covid-19 immunization and experienced occasional chills and aches. It was reported that She explained she was achy and sored. She added her symptoms are on and off and were worst the day after the shot. She specified she had a swollen lymph node in the at the back of her head and under her arm. She added she felt nerve pain and muscle pain in her neck and it felt hot in the back of her neck. She asked if her symptoms were reported as side effects to the vaccine. She also asked how long the side effects can last. The outcome for the events was reported as unknown at the time of this report.   Information on the lot/batch number has been requested  Follow-up (02Apr2021): This follow-up is being submitted to notify that the lot/batch number is not available despite the follow-up attempts made. Follow-up attempts have been completed and no further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Pain
Clinical narrative: achy and sored; she felt "nerve pain and muscle pain in [her] neck; hot in the back of [her] neck; nerve pain and muscle pain in [her] neck; swollen lymph node in the at the back of [her] head and under [her] arm; she felt "nerve pain and muscle pain in [her] neck; This is a spontaneous report from a contactable consumer or other non hcp (Patient).  A 37-years-old female patient received second dose of bnt162b2 (BNT162B2, PFIZER-BIOTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number was not reported), via an unspecified route of administration on 08Feb2021 as single dose for covid-19 immunization. No medical history and no concomitant medications were not reported. Historical vaccine included first dose of BNT162B2 for Covid-19 immunization and experienced occasional chills and aches. It was reported that She explained she was achy and sored. She added her symptoms are on and off and were worst the day after the shot. She specified she had a swollen lymph node in the at the back of her head and under her arm. She added she felt nerve pain and muscle pain in her neck and it felt hot in the back of her neck. She asked if her symptoms were reported as side effects to the vaccine. She also asked how long the side effects can last. The outcome for the events was reported as unknown at the time of this report.   Information on the lot/batch number has been requested  Follow-up (02Apr2021): This follow-up is being submitted to notify that the lot/batch number is not available despite the follow-up attempts made. Follow-up attempts have been completed and no further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Pain in jaw
Clinical narrative: jaw pain; This is a spontaneous report from a contactable consumer (patient). A 69-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Formulation: Solution for injection, Lot number and expiration date was not reported) via an unspecified route of administration on an unspecified date as dose 1, single for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient experienced jaw pain on an unspecified date. It was reported that, she also had jaw pain when she took a Merck product before. She wanted to know if there were reported case for jaw pain and if the pain would be worst after the 2nd dose. Patient took Advil to manage the pain in her jaw and was asking if it was ok. The outcome of the event was unknown.  Information about lot/Batch number has been requested.  Follow-up attempts are completed. No further information is expected.
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea, Nausea, Vomiting
Clinical narrative: Vomited/threw up the next day; Nausea; Diarrhea; This is a spontaneous report from a contactable consumer (patient's daughter; caregiver). This consumer reported for a female patient (mother) that, the 80-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection, Batch/Lot Number: Unknown, Expiry Date: Unknown), dose 1 via an unspecified route of administration, administered in Arm Left on 04Feb2021 at 11:15 (at the age of 80-years-old) as a DOSE 1, SINGLE for covid-19 immunisation at hospital. The patient medical history was none. There were no concomitant medications. She had no other vaccines on the same day or in the 4 weeks prior. On 05Feb2021, the patient had vomited/threw up the next day, nausea (lasted for 8 Days) and diarrhea (lasted for 7 Days). Reporter stated that, her mother (patient) received the first dose of the pfizer vaccine on 4Feb2021 and after getting first dose experienced, vomiting, nausea, and diarrhea. Reporter asked, are these normal side effects. In the trials anything to treat the symptoms? would these side effects be a contraindication to getting the 2nd dose? these side effects were not severe, but they lingered on for over a week. It wasn't life-threatening but my concern was regarding the 2nd dose (scheduled to get on 27Feb2021), if it would be worse? or would she have the same type of reaction again? or maybe no reaction at or maybe something more intense? Reporter's mom (patient) who was 80 years old had received her first COVID shot. She became nauseous and has on and off diarrhea for about a week now. Reporter was asking if her mother should get the second shot. Reporter stated that, she was calling about the Covid Vaccine. She was reporting on behalf of her mom (patient), she was 80 years old, she got vaccine first dose on 04Feb2021, she threw up the next day, then the next week she had bouts of nausea, and occasional diarrhea over a week. Reporter was concerned, she asked is that a normal side effect, what do they do about it, and is she okay with getting the second shot. Reporter clarified that the First Dose was on 04Feb2021 at 11:15AM, then on 05Feb2021 she vomited one time after breakfast, then that same day afternoon she had diarrhea, and also had diarrhea on 06Feb2021. She is finally past that, on Saturday 13Feb2021 she recalled patient was saying that is the first day she did not have nausea. On the first day patient had one occurrence of diarrhea, then on the second it was 2-3, after that it stopped and on the 12Feb2021 she had her last episode in the morning. Patient had no visit to the emergency room or doctor's office because of the symptoms she experienced. Reporter had no relevant family medical history that she would like to share. Outcome of the event Vomited/threw up the next day was resolved on 05Feb2021, Diarrhea was resolved on 12Feb2021 and Nausea was resolved on 13Feb2021.  Information about lot/batch number has been requested.  Follow-up (13May2021): Follow-up attempts completed. No further information expected.
Age: 79.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Dyspepsia, Eructation, Fatigue, Flatulence, Pain
Clinical narrative: sharp pain in her right side; indigestion; burping; feeling like she has air inside like a rolling fart; fatigue; This is a spontaneous report from a contactable consumer. This 79-year-old female consumer (patient) reported.  A 79-year-old (non-pregnant) female patient received a dose of BNT162B2 (BNT162B2, Formulation: Solution for injection, Lot Number: unknown, Expiration date: unknown), via unspecified route, administered in left arm on 16Feb2021 (at the age of 79-year-old) as dose 2, single for COVID-19 immunization. Patient received a dose of BNT162B2 (BNT162B2, Formulation: Solution for injection, Lot Number: unknown, Expiration date: unknown), via unspecified route, administered on an unspecified date (at the age of 79-year-old) as dose 1, single for COVID-19 immunization and patient experienced Fatigue. The patient medical history include Appendicitis from an unknown onset and unknown ongoing and concomitant medications were not reported. On an unspecified date, after the vaccination, she states she took a nap and upon awakening she developed a sharp pain in her right side which she feels like could be appendicitis and that gets worse when she walks around. She also reports indigestion, burping, feeling like she has air inside like a rolling fart.  She states after her first dose of the vaccine, she only felt fatigued for a couple of days. She wonders about appendicitis. The outcome of the events was unknown.  No follow-up attempts possible. No further information expected.  Follow-up (01Apr2021): This follow-up is being submitted to notify that the lot/batch number is not available despite the follow-up attempts made. Follow-up attempts have been completed and no further information is expected.
Age: 79.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Fatigue
Clinical narrative: sharp pain in her right side; indigestion; burping; feeling like she has air inside like a rolling fart; fatigue; This is a spontaneous report from a contactable consumer. This 79-year-old female consumer (patient) reported.  A 79-year-old (non-pregnant) female patient received a dose of BNT162B2 (BNT162B2, Formulation: Solution for injection, Lot Number: unknown, Expiration date: unknown), via unspecified route, administered in left arm on 16Feb2021 (at the age of 79-year-old) as dose 2, single for COVID-19 immunization. Patient received a dose of BNT162B2 (BNT162B2, Formulation: Solution for injection, Lot Number: unknown, Expiration date: unknown), via unspecified route, administered on an unspecified date (at the age of 79-year-old) as dose 1, single for COVID-19 immunization and patient experienced Fatigue. The patient medical history include Appendicitis from an unknown onset and unknown ongoing and concomitant medications were not reported. On an unspecified date, after the vaccination, she states she took a nap and upon awakening she developed a sharp pain in her right side which she feels like could be appendicitis and that gets worse when she walks around. She also reports indigestion, burping, feeling like she has air inside like a rolling fart.  She states after her first dose of the vaccine, she only felt fatigued for a couple of days. She wonders about appendicitis. The outcome of the events was unknown.  No follow-up attempts possible. No further information expected.  Follow-up (01Apr2021): This follow-up is being submitted to notify that the lot/batch number is not available despite the follow-up attempts made. Follow-up attempts have been completed and no further information is expected.
Age: 79.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Dyspepsia, Eructation, Fatigue, Flatulence, Pain
Clinical narrative: fatigued; This is a spontaneous report from a contactable consumer(Patient). A 79-years-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection; Batch/Lot number was not reported), via an unspecified route of administration on an unspecified date (at the age of 79-years-old) as a single dose for COVID-19 immunisation. Medical history included appendicitis from an unknown date and unknown if ongoing. The patient's concomitant medications were not reported. On an unknown date, the patient experienced fatigued. She states after her first dose of the vaccine, she only felt fatigued for a couple of days. She wonders about appendicitis. The first vaccine she just had a lot of fatigue, and she slept a lot. The same thing happened after the second. She laid down in bed, and when tried to get up, she had a sharp pain in her right side. Which she feels like could be appendicitis. She knows she has no way of knowing that.The outcome of the event was unknown.  Information on the lot/batch number has been requested.  Follow-up attempts are completed. No further information is expected.
Age: 79.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Fatigue
Clinical narrative: fatigued; This is a spontaneous report from a contactable consumer(Patient). A 79-years-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection; Batch/Lot number was not reported), via an unspecified route of administration on an unspecified date (at the age of 79-years-old) as a single dose for COVID-19 immunisation. Medical history included appendicitis from an unknown date and unknown if ongoing. The patient's concomitant medications were not reported. On an unknown date, the patient experienced fatigued. She states after her first dose of the vaccine, she only felt fatigued for a couple of days. She wonders about appendicitis. The first vaccine she just had a lot of fatigue, and she slept a lot. The same thing happened after the second. She laid down in bed, and when tried to get up, she had a sharp pain in her right side. Which she feels like could be appendicitis. She knows she has no way of knowing that.The outcome of the event was unknown.  Information on the lot/batch number has been requested.  Follow-up attempts are completed. No further information is expected.
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Lymph node pain, Myalgia, Vaccination site erythema, Vaccination site pruritus, Vaccination site warmth
Clinical narrative: Muscle soreness left neck; Visible and painful lymph nodes 1- just above clavicle 2- below clavicle; At injection site raised, red, warm and itchy; At injection site raised, red, warm and itchy; At injection site raised, red, warm and itchy; This is a spontaneous report from a contactable Other HCP(Patient). A 47-years-old non pregnant female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection; Lot number EL9267), via an unspecified route of administration on 13Feb2021 at 08:30(at the age of 47-years-old) administered in Arm Left as a single dose for COVID-19 immunisation. The patient had received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection; Lot number EL9262), via an unspecified route of administration on 23jan2021 at 08:15 administered in Arm Left as a single dose for COVID-19 immunisation. Medical history included hypertension from an unknown date and unknown if ongoing. Concomitant medication(s) included amlodipine; atenolol (all taken for an unspecified indication, start and stop date were not reported). The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19.The patient previously took diovan and experienced allergy. On 14Feb2021 at 17:00 PM, the patient experienced at injection site raised, red, warm and itchy. Has increased to 2.5 inches in diameter. Visible and painful lymph nodes, 1 just above clavicle, 2 below clavicle. Close to shoulder joint. Muscle soreness left neck. No treatment was given for the events. The outcome of the events was not recovered.   Follow-up (14May2021): Follow-up attempts completed. No further information expected.
Age: 39.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Feeling abnormal
Clinical narrative: head feels foggy; extremely tired; This is a spontaneous report from a contactable Consumer or other non-HCP (patient). An Adult 39-year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Lot number: el3247), dose 1 via an unspecified route of administration, administered in Arm Left on 28Jan2021 at 09:00 AM (at the age of 39-year-old), as DOSE 1, SINGLE for covid-19 immunisation. The patient medical history was not reported. There were no concomitant medications. The patient had no COVID prior to vaccination. The patient previously took codeine and experienced allergies. No other vaccine in four weeks. No other medications in two weeks. The patient had not been COVID tested post vaccination. On 11Feb2021, the patient experienced head feels foggy and extremely tired. No treatment was received to treat the events. It was reported that on the 16Feb, patient was feeling extremely tired which was why he filed the AE report. In hindsight as he was filling out the report, then realized he had been feeling some slight tiredness for the past week which was why he put AE date as 11Feb. But it did not really reach the level that he noticed it until the 16thFeb. The patient outcome of the events was not resolved at the time of this report.  Follow-up attempts completed. No further information expected.
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: Achy arm; This is a spontaneous report from a non-contactable consumer (patient). A non-pregnant 39-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot Number: EN5318), via an unspecified route of administration in left arm, on 16Feb2021 at 10:30 AM (at the age of 39 years), as dose 2, single, for COVID-19 immunization. The patient's medical history was not reported. There were no concomitant medications. The patient previously received the first dose of BNT162B2 (Lot Number: EN5318) on 26Jan2021 (at the age of 39 years) for COVID-19 immunization. The patient was not diagnosed with COVID-19 prior vaccination. No other vaccine was administered in four weeks. The vaccine was administered in a workplace clinic facility. The patient needed clarification on definition of adverse event versus expected reaction such as achy arm and body aches. The patient asked if expected effects need to be reported. In Feb2021, the patient had an achy arm so far after receiving the second dose. No treatment was administered for the adverse event. The patient has not been tested for COVID-19 post vaccination. The patient was recovering from the event.  No follow-up attempts are possible. No further information is expected.
Sex: M
Vaccine: COVID19
Symptoms: Pain, Pain in extremity
Clinical narrative: achy arm; body aches; This is a spontaneous report from a non-contactable consumer. A male patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as DOSE 2, SINGLE for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. On an unspecified date, it was reported that the patient had an achy arm and body aches for 12 hours after receiving his second dose of the vaccine. No other details other than he was fine after 12 hours was reported. It was unknown if the patient received treatment for the events. It was unknown if the patient was diagnosed with COVID-19 prior to vaccination or tested for COVID-19 post vaccination. On an unspecified date, the outcome of events was recovered.  No follow up attempts are possible. Information on the lot/batch number has been requested. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Pruritus, Scratch
Clinical narrative: I started scratching approximately 3 days after I received the first dose of the Pfizer vaccine.; I started scratching approximately 3 days after I received the first dose of the Pfizer vaccine/she was scratching throughout the day and night and would wake up very itchy in the morning; This is a spontaneous report from a contactable consumer (patient) reported for herself. A 68-years-old female patient (patient was not pregnant at the time of vaccination) received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number: E13246, Expiration date: unknown) via an unspecified route of administration, administered in left arm on 12Jan2021 at 12:00 pm (age at vaccination was unknown) as dose 1, single for COVID-19 immunization. The patient's medical history was not reported. The patient did not have any known allergies. The patient was in excellent health and was never sick. The patient did not receive any concomitant medications or other medications in two weeks. The facility where the most recent COVID-19 vaccine was administered was Hospital. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. On 15Jan2021, the patient started scratching approximately 3 days after she received the first dose of the Pfizer vaccine. She assumed that she must have gotten some mosquito bites. After the 4th day when she was still scratching, she started taking Benadryl every 4 hours or so. After several days of that, she contacted her doctor's office and advised of her reaction and that she had been taking Benadryl for several days. They prescribed a 6 day steroid pack for her but did not advise her to continue with the Benadryl which she stopped as soon as she started on the steroid pack. When the steroid tablets wore off, she started scratching again. She started back up on the Benadryl on the 4th day of the steroids. When she finished the 6 days of the steroids, she was scratching throughout the day and night and would wake up very itchy in the morning and continue to do so. She spoke with her doctor, plus the dermatologist that she saw that day, as well as the Director of Nursing and Pharmacist from the hospital's vaccination. The adverse events resulted in Doctor or other healthcare professional office/clinic visit. The outcome of the events was unknown.   Follow-up attempts are completed. No further information is expected.
Age: 82.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: Sore Arm at point of injection; This is a spontaneous report from a non-contactable consumer (patient). An 82-year-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration, administered in Arm Left on 16Feb2021 09:00 (Batch/Lot number was not reported) as DOSE NUMBER UNKNOWN, SINGLE for covid-19 immunisation. Medical history included Known allergies: penicillin. The patient's concomitant medications were not reported. On 16Feb2021 18:00, the patient experienced Sore Arm at point of injection. The outcome of the event was recovering. The patient did not have COVID prior vaccination. The patient was not COVID tested post vaccination.  Information about lot/batch has been requested.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain upper, Headache
Clinical narrative: headaches and stomach aches; headaches and stomach aches; This is a spontaneous report from a contactable consumer (patient) via Covid-19 self reporting system. A 72-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration, administered in Arm Left on 11Feb2021 08:30 (lot number and expiry date: unknown) at the age of 72-years-old, as dose 1, single, for Covid-19 immunisation. Medical history included high blood pressure and diabetes. The patient had no known allergies. Concomitant medications included telmisartan; glimepiride; carvedilol; and atorvastatin taken for unspecified indications, start and stop dates were not reported. The vaccine was administered in a hospital. The patient was not pregnant at the time of vaccination. The patient was not diagnosed with COVID prior vaccination. The patient has not been tested for COVID-19 since vaccination. The patient experienced headaches and stomach aches on 11Feb2021. The patient did not receive treatment for the events. Outcome of the events was not recovered.  No follow-up attempts are possible; information about lot/batch number cannot been obtained. No further information is expected.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Blood triglycerides, Blood triglycerides decreased
Clinical narrative: triglycerides were a little off; This is a spontaneous report from a contactable Other healthcare professional. A 64-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN), dose 1 via an unspecified route of administration on 11Jan2021 (at the age of 64-years-old) as a single dose for covid-19 immunization and received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN), dose 2 via an unspecified route of administration on 08Feb2021 as a single dose for covid-19 immunization. The patient's medical history and concomitant medications were not reported. The patient reported since 11Dec2020 and ongoing: noticing changes in some joints such as the top of her right pinky fingers has a new nodule and is painful, also she stated she has fluid build up behind her right knee. She also reported that due to changing weather, she has some joints that are currently a little sore. The patient did not have covid-19 and also had blood work with her cardiologist showing all positive results except triglycerides were a little off on an unspecified date. No additional information provided. Outcome of the event was unknown. Information on the Lot/batch number has been requested. Follow-up attempts completed. No further information expected.
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Hypoaesthesia, Injection site erythema
Clinical narrative: injection site with redness; My arm was numb from the top of my shoulder to my elbow; This is a spontaneous report from a contactable other hcp. A 36-years-old female patient received bnt162b2 (Pfizer BioNTech, Solution for injection, Lot number was not reported), via an unspecified route of administration, administered in Arm Right on 15Feb2021 as 2nd dose single for covid-19 immunisation (Age at vaccination was 36 years). Patient was not pregnant at time of vaccination. Past drug event was clindamycin. Historical vaccine was A 36-years-old female patient received bnt162b2 (Pfizer BioNTech, Solution for injection, Lot number was not reported), via an unspecified route of administration, administered in Arm Right on 22Jan2021 as 1stdose single for covid-19 immunisation. Medical history included drug hypersensitivity from an unknown date and unknown if ongoing, food allergy from an unknown date and unknown if ongoing.  Concomitant medication(s) included cetirizine hcl (CETIRIZINE HCL) taken for an unspecified indication, start and stop date were not reported.  The patient previously took clindamycin and experienced drug hypersensitivity, bnt162b2 for covid-19 immunisation.  The patient experienced injection site with redness, my arm was numb from the top of my shoulder to my elbow on 15Feb2021 12:45. Upon follow-up on 12MAY2021 follow-up attempts completed. No further information expected. Outcome of the events not recovered.    Follow-up (12MAY2021): Follow-up attempts completed. No further information expected.
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Dysphagia, Mutism, Tongue blistering
Clinical narrative: Severe blisters on the tongue; unable to swallow and talk; unable to swallow and talk; This is a spontaneous report from a contactable other health professional (patient). A 37-year-old non pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot Number: el9266) via intramuscular route of administration, administered in Arm Left on 12Feb2021 (at the age of 37 years old) as dose 2, single for COVID-19 immunisation at hospital. Medical history included known allergies. There were no concomitant medications patient received within two weeks of COVID vaccine. Patient historical vaccine included first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot Number: en9266) via intramuscular route of administration, administered in Arm Left on 22Jan2021 (at the age of 37 years old) as single for COVID-19 immunisation. Patient did not received other vaccine within four weeks of COVID vaccine. Patient did not have COVID prior to vaccination. The patient experienced severe blisters on the tongue, unable to swallow and talk on 15Feb2021. No treatment were given for the events. Outcome of all the events were not resolved.  Follow-up attempts completed. No further information expected.
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: arm  pain; This is a spontaneous report from a non-contactable consumer (patient). An adult female patient received BNT162B2 (Pfizer-BioNTech COVID-19 vaccine), via an unspecified route of administration on Jan2021 (lot number was not reported) as dose number unknown, single for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient experienced arm pain on the day and on the next day of the vaccination on an unknown date in Jan2021. The outcome of the event was unknown.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: U
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: right upper arm pain developed; This is a spontaneous report from a non-contactable consumer. This adult consumer (patient) reported that: An adult patient of an unspecified gender received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection, Batch/Lot number was not reported), via an unspecified route of administration, administered in Arm Right on Feb2021 as single dose for covid-19 immunisation. The patient medical history and concomitant medications were not reported. Patient reported from the night of the vaccination, right upper arm pain developed on an unspecified date in Feb2021, 2 days after the vaccination, recovering. Patient received second dose of vaccination on an unspecified date, few hours after the vaccination, right upper arm pain developed. The pain was little stronger than the 1st dose. On the Second day of the vaccination, in the afternoon, there were mild sleepiness and malaise, which were recovering on the third day. The outcome of the event was reported as recovering.   No follow-up attempts are possible. Information about Lot/Batch could not be obtained. No further information is expected.
Sex: U
Vaccine: COVID19
Symptoms: Fatigue, Malaise, Pain
Clinical narrative: fatigue; The pain was not strong; malaise; This is a spontaneous report from a non-contactable consumer or other non-hcp. A adult patient of an unspecified gender received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: solution for injection; Batch/Lot Number: Unknown, Expiration date: Unknown) via an unspecified route of administration on an unspecified date in Jan2021 as dose 2, single for COVID-19 immunization. The patient medical history and concomitant medications were not reported. Historical vaccine includes first dose of BNT162B2 administered on an unspecified date for COVID-19 immunization; 6 hours after first inoculation the patient experienced strong pain at the inoculation site. On an unspecified date the patient experienced with second inoculation the pain was not strong, but malaise and fatigue developed the next day. The clinical outcome of the events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021319946 Same reporter, patient different dose.
Sex: F
Vaccine: COVID19
Symptoms: Influenza like illness
Clinical narrative: flu like symptoms; This is a spontaneous report from a contactable Other-HCP and a contactable consumer. A 69-years-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, formulation: solution for injection, lot number: unknown, expiry date: unknown) via unspecified route of administration on an unspecified date as dose number unknown, single for covid-19 immunisation. Patients medical history and concomitant medications were not reported. Since starting therapy the patient had been having slight headaches and neck pain at times symptoms come and go and not bothersome also reported that she has received her covid-19 vaccination, and experienced flu like symptoms on an unspecified date after lasted about 24 hours then went away without medical intervention. The patient agreed to monitor her symptoms and notify the physician if her symptoms persist or worsen. Treatment regimen was given as a result of the adverse event. The outcome of event was recovered on an unspecified date.   Follow-up attempts completed. No further information expected.
Age: 33.0
Sex: M
Vaccine: COVID19
Symptoms: Headache, Pain
Clinical narrative: Headache; body aches; This is a spontaneous report from a contactable consumer or other non-hcp (Patient). A 33-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: solution for injection; Batch/Lot Number: Unknown, Expiration date: Unknown) via an unspecified route of administration (age at vaccination 33-year) in left arm on 16Feb2021 at 10:30 AM as dose 2, single for COVID-19 immunization. The patient medical history and concomitant medications were not reported. No known allergies were reported. Historical vaccine includes first dose of BNT162B2 administered in left arm on 26Jan2021 at 10:30 AM for COVID-19 immunization. Reported facility type vaccine was workplace clinic. The patient received no other vaccine in four weeks, and no other medications in two weeks. No COVID prior vaccination was reported. The patient not tested COVID post vaccination. On 17Feb2021 at 06:00 AM the patient experienced headache and body aches when waking up. The patient received no treatment for the adverse events. The clinical outcome of the events was unknown.   Follow-up attempts completed. No further information expected.
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Diarrhoea, Fatigue, Feeling abnormal, Migraine
Clinical narrative: Migraine; chills; foggy head; muscle aches; tiredness; diarrhea; This is a spontaneous report from a contactable consumer or other non hcp (patient). A 45-year-old non-pregnant female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for Injection, Batch/Lot Number: eln266), via an unspecified route of administration, administered in arm left on 15Feb2021 at 08:15 AM (at the age of 45-year-old) as dose 2, single for COVID-19 immunization. The patient medical history included asthma, irritable bowel syndrome (IBS), high blood pressure, COVID-19 (If COVID prior vaccination: Yes), all from an unknown date and unknown if ongoing. The patient's concomitant medications were not reported. Patient had no known allergies. The patient did not receive any other vaccine in four weeks. Patient was diagnosed with COVID prior vaccination. Patient had not been COVID tested post vaccination. The patient previously took first dose of bnt162b2 for COVID-19 immunization. On 15Feb2021 at 20:00 (08:00 PM), the patient experienced migraine, chills, foggy head, muscle aches, tiredness, diarrhea. The patient did not receive treatment for the events. Outcome of all the events was recovered on an unspecified date in 2021.  Follow-up (PRD/SRD 11May2021): Follow-up attempts completed. No further information expected.
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia
Clinical narrative: Migraine; chills; foggy head; muscle aches; tiredness; diarrhea; This is a spontaneous report from a contactable consumer or other non hcp (patient). A 45-year-old non-pregnant female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for Injection, Batch/Lot Number: eln266), via an unspecified route of administration, administered in arm left on 15Feb2021 at 08:15 AM (at the age of 45-year-old) as dose 2, single for COVID-19 immunization. The patient medical history included asthma, irritable bowel syndrome (IBS), high blood pressure, COVID-19 (If COVID prior vaccination: Yes), all from an unknown date and unknown if ongoing. The patient's concomitant medications were not reported. Patient had no known allergies. The patient did not receive any other vaccine in four weeks. Patient was diagnosed with COVID prior vaccination. Patient had not been COVID tested post vaccination. The patient previously took first dose of bnt162b2 for COVID-19 immunization. On 15Feb2021 at 20:00 (08:00 PM), the patient experienced migraine, chills, foggy head, muscle aches, tiredness, diarrhea. The patient did not receive treatment for the events. Outcome of all the events was recovered on an unspecified date in 2021.  Follow-up (PRD/SRD 11May2021): Follow-up attempts completed. No further information expected.
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: Malaise, Ocular discomfort, Pallor, Rhinorrhoea
Clinical narrative: had a little bit of sniffles; his eyes were a little weird; he's not feeling well; He was pale; This is a spontaneous report from a contactable consumer or other non hcp (male patient (boyfriend).   A 71-years-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot No was not reported), via an unspecified route of administration on an unspecified date as 2nddose, single for covid-19 immunisation (Age at vaccination was 71 years). Historical vaccine was A 71-years-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot No was not reported), via an unspecified route of administration on an unspecified date as 1stdose, single for covid-19 immunisation. He had no side effects after his first shot. The patient medical history and concomitant medications were not reported.  The patient experienced had a little bit of sniffles, his eyes were a little weird, he's not feeling well, he was pale on an unspecified date. She states she could look at him in a second and know he's not feeling well. He was pale, but he is feeling good now also stated her sister's son's father-in-law (65 years old) caught COVID twice and suffered a stroke and got the same treatment that the president received, and he is feeling well. The outcome of had a little bit of sniffles, his eyes were a little weird, he's not feeling well on an was unknown, he was pale was recovering.  Information on lot number/batch number has been requested.  Follow-up attempts are completed. No further information is expected.
Age: 41.0
Sex: M
Vaccine: COVID19
Symptoms: Headache, Nasopharyngitis, Neck pain, Pain in extremity
Clinical narrative: Cold like symptoms; sore head, neck and arm; sore head, neck and arm; sore head, neck and arm; This is a spontaneous report from a contactable consumer. A 41-years-old male patient received bnt162b2 (Formulation: Solution for injection; Batch/Lot number was not reported), dose 2 via an unspecified route of administration, administered in Arm Left on 16Feb2021 11:30 as dose 2, single for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient previously received first dose of bnt162b2 via an unspecified route of administration, administered in Arm Left on 26Jan2021 11:30 as dose 1, single for covid-19 immunisation. On 17Feb2021 07:00 AM patient experienced cold like symptoms, sore head, neck and arm. The patient did not received treatment. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The outcome of the events was not recovered.  Information on the lot/batch number has been requested.  Follow-up attempts completed. No further information expected.
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Feeling abnormal
Clinical narrative: I frequently feel like I am on a float in the ocean and it keeps continually moving; keep getting lightheadedness and dizzy spells; This is a spontaneous report from a contactable consumer (patient). A 47-year-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot number: EM9810), via an unspecified route of administration in right arm on 14Feb2021 at 15:00 (at the age of 47-year-old) as dose 1, single for COVID-19 immunisation at hospital. Medical history included MS (multiple sclerosis) from an unknown date and unknown if ongoing. Concomitant medications included colecalciferol (VITAMIN D) and iron supplement taken for an unspecified indication, start and stop date were not reported. The patient had no known allergies. The patient did not diagnose with COVID-19 prior to vaccination. The patient had not been tested for COVID-19 since the vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 15Feb2021, she keeps getting lightheadedness and dizzy spells. She frequently feels like she was on a float in the ocean, and it keeps continually moving. The patient did not receive any treatment for the events. The outcome of events was not resolved.   Follow-up attempts completed. No further information expected.
Sex: M
Vaccine: COVID19
Symptoms: Lymphadenopathy
Clinical narrative: experience  swollen lymph nodes in the left axillary area; This is a spontaneous report from a contactable consumer (patient). A male patient (Age 43; units: Unspecified) received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number and Expiration date was not reported) via an unspecified route of administration on 14Feb2021 as dose number unknown, single for COVID-19 immunization. The patient medical history and concomitant medications were not reported. The patient reported, a reaction to Pfizer covid vaccine to get on the 14Feb2021. On an unspecified date, the patient had experienced swollen lymph nodes in the left axillary area and wanted to know if that is normal. The outcome of the event was unknown.  Follow-up attempts are completed. No further information is expected.
Sex: M
Vaccine: COVID19
Symptoms: Blood test, Pain in extremity
Clinical narrative: Sore arm; This is a spontaneous report from a non-contactable pharmacist (patient) through a Pfizer-sponsored program. A male patient of an unspecified age received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number and expiration date were not reported) on 16Feb2021 as dose 2, single, with route of administration unspecified, for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. In Feb2021, the patient had sore arm. The patient had a blood test on an unspecified date (results were not provided). The outcome of the event was unknown.  No follow-up attempts are possible; information about batch/ lot number cannot be obtained.
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: Sore muscle at injection site; This is a spontaneous report from a non-contactable consumer (patient) through a Pfizer-sponsored program. A male patient of an unspecified age received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number and expiration date were not reported) on 13Feb2021 as dose 1, single, with route of administration unspecified, for COVID-19 immunization).  The patient's medical history and concomitant medications were not reported. On an unspecified date in 2021, the patient had sore muscle at the injection site. The outcome of the event was unknown. The patient had anticipated an epidural treatment with steroids will be ordered for him.  No follow-up attempts are possible. No further information is expected.